Clinical Trial Update: Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma [Phase 3]

View source ↗

Summary

This report covers a Phase 3 trial comparing Oxaliplatin+Gemcitabine versus Capecitabine as adjuvant therapy for intrahepatic cholangiocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Cholangiocarcinoma | Phase 3 | Status: UNKNOWN